Literature DB >> 29025277

Clinical Analysis of Recurrence Patterns in Patients With Nasopharyngeal Carcinoma Treated With Intensity-Modulated Radiotherapy.

Lijun Wang1, Yesong Guo1, Jianhua Xu1, Zhenzhang Chen1, Xuesong Jiang1, Lanfang Zhang2, Shengfu Huang1, Xia He1, Yiqin Zhang1.   

Abstract

OBJECTIVE: To evaluate the characteristics and risk factors for locoregional recurrence in patients with nasopharyngeal carcinoma (NPC) treated with intensity-modulated radiotherapy (IMRT).
METHODS: The clinical diagnosis and treatment data of 195 patients with NPC treated with IMRT from March 2005 to May 2010 (including 9, 24, 70, and 92 cases of stage I, II, III, and IV disease, respectively, according to the 7th edition American Joint Committee on Cancer staging criteria) were retrospectively analyzed. The Kaplan-Meier method was used for survival analysis, and logistic regression was used to conduct univariate and multivariate analyses.
RESULTS: The 5-year recurrence rate was 10.8%, and the 5-year local and regional recurrence rates were 8.7% and 3.4%, respectively. Multivariate analysis showed that the short axis of the cervical lymph nodes (≥3 cm) was an influencing factor for regional lymph node recurrence after IMRT.
CONCLUSION: In-field and high-dose region failures were the main patterns associated with local-regional recurrence, and nasopharyngeal recurrence was most commonly detected. Newly diagnosed patients with large cervical lymph nodes (short diameter ≥3 cm) should be carefully followed up considering regional lymph node recurrence.

Entities:  

Keywords:  intensity-modulated radiotherapy; nasopharyngeal carcinoma; patterns of local-regional failure

Mesh:

Year:  2017        PMID: 29025277     DOI: 10.1177/0003489417734229

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  10 in total

1.  Screening of key miRNAs and evaluation of their diagnostic and prognostic values in nasopharyngeal carcinoma.

Authors:  Xianlu Zhuo; Wei Zhou; Huiping Ye; Dairong Li; Aoshuang Chang; Yongzhong Wu; Qi Zhou
Journal:  Oncol Lett       Date:  2019-04-09       Impact factor: 2.967

2.  SP1-induced AFAP1-AS1 contributes to proliferation and invasion by regulating miR-497-5p/CELF1 pathway in nasopharyngeal carcinoma.

Authors:  Hui Jin; Gengtian Liang; Liping Yang; Li Liu; Binru Wang; Fengqin Yan
Journal:  Hum Cell       Date:  2021-01-05       Impact factor: 4.174

3.  Utility of diffusion-weighted magnetic resonance imaging in predicting the treatment response of nasopharyngeal carcinoma.

Authors:  Thidaporn Tangyoosuk; Chawalit Lertbutsayanukul; Nutchawan Jittapiromsak
Journal:  Neuroradiol J       Date:  2021-11-03

4.  Reirradiation for Recurrent Nasopharyngeal Carcinomas: Experience From an Academic Tertiary Center in a Low- to Middle-Income Country.

Authors:  Ryan Anthony F Agas; Kelvin Ken L Yu; Paolo G Sogono; Lester Bryan A Co; J C Kennetth M Jacinto; Warren R Bacorro; Michael Benedict A Mejia
Journal:  J Glob Oncol       Date:  2019-02

5.  Radiomic Nomogram: Pretreatment Evaluation of Local Recurrence in Nasopharyngeal Carcinoma based on MR Imaging.

Authors:  Lu Zhang; Hongyu Zhou; Dongsheng Gu; Jie Tian; Bin Zhang; Di Dong; Xiaokai Mo; Jing Liu; Xiaoning Luo; Shufang Pei; Yuhao Dong; Wenhui Huang; Qiuyin Chen; Changhong Liang; Zhouyang Lian; Shuixing Zhang
Journal:  J Cancer       Date:  2019-07-10       Impact factor: 4.207

6.  Prognostic value of neutrophils for patients with nasopharyngeal carcinoma.

Authors:  Lisha Chen; Mengying Li; Ting Xu; Xiufang Qiu; Chuanben Chen
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-03-11

7.  A novel dosimetric metrics-based risk model to predict local recurrence in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.

Authors:  Wenjun Liao; Jinlan He; Zijian Liu; Maolang Tian; Jiangping Yang; Jiaqi Han; Jianghong Xiao
Journal:  Radiat Oncol       Date:  2021-09-23       Impact factor: 3.481

8.  Combination of IFITM1 knockdown and radiotherapy inhibits the growth of oral cancer.

Authors:  Jie Yang; Lei Li; Yan Xi; Ruimei Sun; Hu Wang; Yanxin Ren; Liufang Zhao; Xiaoli Wang; Xiaojiang Li
Journal:  Cancer Sci       Date:  2018-09-21       Impact factor: 6.716

9.  Long-Term Survival After Nasopharyngeal Carcinoma Treatment in a Local Prefecture-Level Hospital in Southern China.

Authors:  Yun Du; Wentong Zhang; Feng Lei; Xia Yu; Zhuming Li; Xiaodong Liu; Yanan Ni; Li Deng; Mingfang Ji
Journal:  Cancer Manag Res       Date:  2020-02-24       Impact factor: 3.989

Review 10.  Clinical utility of Epstein-Barr virus DNA and other liquid biopsy markers in nasopharyngeal carcinoma.

Authors:  Rong Tan; Sean Kean Ann Phua; Yoke Lim Soong; Lynette Lin Ean Oon; Kian Sing Chan; Sasidharan Swarnalatha Lucky; Jamie Mong; Min Han Tan; Chwee Ming Lim
Journal:  Cancer Commun (Lond)       Date:  2020-09-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.